世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035501

免疫診断の世界市場(2023-2027)

TechNavio

Global Immunodiagnostics Market 2023-2027

発刊日 2023/04/28

言語英語

体裁PDF/169ページ

ライセンス/価格169ページ

0000035501

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

免疫診断市場は、2022年から2027年の間に226億6,975万米ドル成長すると予測されており、予測期間中に12%のCAGRで加速すると予測されています。免疫診断市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、バイオマーカーに基づく検査の需要の増加、免疫診断技術の進歩、および高齢者人口の増加によって牽引されています。

免疫診断市場は次のように分類されます。

  • 製品別
    ➣ 試薬および消耗品
    ➣ 免疫診断システム
  • 用途別
    ➣ 腫瘍学および内分泌学
    ➣ 肝炎とレトロウイルス
    ➣ 感染症
    ➣ 消化管便
    ➣ その他の用途
  • 地域別
    ➣ 北アメリカ
    ➣ ヨーロッパ
    ➣ アジア
    ➣ 世界のその他の地域

この調査は、個別化医療に対する需要の増加が、今後数年間の免疫診断市場の成長を促進する主な理由の 1 つであることを特定しています。また、ポイントオブケア検査(POCT)の出現と自動システムへの需要の高まりにより、市場での需要が大幅に増加すると予想されます。

免疫診断市場に関するレポートは、次の分野をカバーしています。

  • 免疫診断市場の規模
  • 免疫診断市場の予測
  • 免疫診断市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、免疫診断市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ Adaptive Biotechnologies Corp.
    ➣ AESKU.GROUP GmbH and Co. KG
    ➣ bioMerieux SA
    ➣ Danaher Corp.
    ➣ DiaSorin SpA
    ➣ F. Hoffmann La Roche Ltd.
    ➣ HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
    ➣ OraSure Technologies Inc.
    ➣ QuidelOrtho Corp.
    ➣ Siemens AG
    ➣ SQI Diagnostics Inc.
    ➣ Sysmex Corp.
    ➣ Tecan Trading AG
    ➣ Thermo Fisher Scientific Inc.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global immunodiagnostics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global immunodiagnostics market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Reagents and consumables - Market size and forecast 2022-2027
Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
6.4 Immunodiagnostic systems - Market size and forecast 2022-2027
Exhibit 38: Chart on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application
7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022-2027 (%)
Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Oncology and endocrinology - Market size and forecast 2022-2027
Exhibit 48: Chart on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
7.4 Hepatitis and retrovirus - Market size and forecast 2022-2027
Exhibit 52: Chart on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
7.5 Infectious disease - Market size and forecast 2022-2027
Exhibit 56: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
7.6 GI stool - Market size and forecast 2022-2027
Exhibit 60: Chart on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on GI stool - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on GI stool - Year-over-year growth 2022-2027 (%)
7.7 Other applications - Market size and forecast 2022-2027
Exhibit 64: Chart on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Other applications - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Other applications - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Application
Exhibit 68: Market opportunity by Application ($ million)
Exhibit 69: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 119: Abbott Laboratories - Overview
Exhibit 120: Abbott Laboratories - Business segments
Exhibit 121: Abbott Laboratories - Key news
Exhibit 122: Abbott Laboratories - Key offerings
Exhibit 123: Abbott Laboratories - Segment focus
12.4 Adaptive Biotechnologies Corp.
Exhibit 124: Adaptive Biotechnologies Corp. - Overview
Exhibit 125: Adaptive Biotechnologies Corp. - Product / Service
Exhibit 126: Adaptive Biotechnologies Corp. - Key offerings
12.5 AESKU.GROUP GmbH and Co. KG
Exhibit 127: AESKU.GROUP GmbH and Co. KG - Overview
Exhibit 128: AESKU.GROUP GmbH and Co. KG - Product / Service
Exhibit 129: AESKU.GROUP GmbH and Co. KG - Key offerings
12.6 bioMerieux SA
Exhibit 130: bioMerieux SA - Overview
Exhibit 131: bioMerieux SA - Product / Service
Exhibit 132: bioMerieux SA - Key offerings
12.7 Danaher Corp.
Exhibit 133: Danaher Corp. - Overview
Exhibit 134: Danaher Corp. - Business segments
Exhibit 135: Danaher Corp. - Key news
Exhibit 136: Danaher Corp. - Key offerings
Exhibit 137: Danaher Corp. - Segment focus
12.8 DiaSorin SpA
Exhibit 138: DiaSorin SpA - Overview
Exhibit 139: DiaSorin SpA - Business segments
Exhibit 140: DiaSorin SpA - Key news
Exhibit 141: DiaSorin SpA - Key offerings
Exhibit 142: DiaSorin SpA - Segment focus
12.9 F. Hoffmann La Roche Ltd.
Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
12.10 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
Exhibit 148: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibit 149: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
Exhibit 150: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
12.11 OraSure Technologies Inc.
Exhibit 151: OraSure Technologies Inc. - Overview
Exhibit 152: OraSure Technologies Inc. - Business segments
Exhibit 153: OraSure Technologies Inc. - Key offerings
Exhibit 154: OraSure Technologies Inc. - Segment focus
12.12 QuidelOrtho Corp.
Exhibit 155: QuidelOrtho Corp. - Overview
Exhibit 156: QuidelOrtho Corp. - Product / Service
Exhibit 157: QuidelOrtho Corp. - Key offerings
12.13 Siemens AG
Exhibit 158: Siemens AG - Overview
Exhibit 159: Siemens AG - Business segments
Exhibit 160: Siemens AG - Key news
Exhibit 161: Siemens AG - Key offerings
Exhibit 162: Siemens AG - Segment focus
12.14 SQI Diagnostics Inc.
Exhibit 163: SQI Diagnostics Inc. - Overview
Exhibit 164: SQI Diagnostics Inc. - Product / Service
Exhibit 165: SQI Diagnostics Inc. - Key offerings
12.15 Sysmex Corp.
Exhibit 166: Sysmex Corp. - Overview
Exhibit 167: Sysmex Corp. - Business segments
Exhibit 168: Sysmex Corp. - Key offerings
Exhibit 169: Sysmex Corp. - Segment focus
12.16 Tecan Trading AG
Exhibit 170: Tecan Trading AG - Overview
Exhibit 171: Tecan Trading AG - Business segments
Exhibit 172: Tecan Trading AG - Key offerings
Exhibit 173: Tecan Trading AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 174: Thermo Fisher Scientific Inc. - Overview
Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
Exhibit 176: Thermo Fisher Scientific Inc. - Key news
Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global immunodiagnostics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Application - Market share 2022-2027 (%)
Exhibits45: Data Table on Application - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on GI stool - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on GI stool - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Other applications - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Other applications - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Application ($ million)
Exhibits69: Data Table on Market opportunity by Application ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories - Overview
Exhibits120: Abbott Laboratories - Business segments
Exhibits121: Abbott Laboratories - Key news
Exhibits122: Abbott Laboratories - Key offerings
Exhibits123: Abbott Laboratories - Segment focus
Exhibits124: Adaptive Biotechnologies Corp. - Overview
Exhibits125: Adaptive Biotechnologies Corp. - Product / Service
Exhibits126: Adaptive Biotechnologies Corp. - Key offerings
Exhibits127: AESKU.GROUP GmbH and Co. KG - Overview
Exhibits128: AESKU.GROUP GmbH and Co. KG - Product / Service
Exhibits129: AESKU.GROUP GmbH and Co. KG - Key offerings
Exhibits130: bioMerieux SA - Overview
Exhibits131: bioMerieux SA - Product / Service
Exhibits132: bioMerieux SA - Key offerings
Exhibits133: Danaher Corp. - Overview
Exhibits134: Danaher Corp. - Business segments
Exhibits135: Danaher Corp. - Key news
Exhibits136: Danaher Corp. - Key offerings
Exhibits137: Danaher Corp. - Segment focus
Exhibits138: DiaSorin SpA - Overview
Exhibits139: DiaSorin SpA - Business segments
Exhibits140: DiaSorin SpA - Key news
Exhibits141: DiaSorin SpA - Key offerings
Exhibits142: DiaSorin SpA - Segment focus
Exhibits143: F. Hoffmann La Roche Ltd. - Overview
Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits145: F. Hoffmann La Roche Ltd. - Key news
Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits148: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibits149: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
Exhibits150: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
Exhibits151: OraSure Technologies Inc. - Overview
Exhibits152: OraSure Technologies Inc. - Business segments
Exhibits153: OraSure Technologies Inc. - Key offerings
Exhibits154: OraSure Technologies Inc. - Segment focus
Exhibits155: QuidelOrtho Corp. - Overview
Exhibits156: QuidelOrtho Corp. - Product / Service
Exhibits157: QuidelOrtho Corp. - Key offerings
Exhibits158: Siemens AG - Overview
Exhibits159: Siemens AG - Business segments
Exhibits160: Siemens AG - Key news
Exhibits161: Siemens AG - Key offerings
Exhibits162: Siemens AG - Segment focus
Exhibits163: SQI Diagnostics Inc. - Overview
Exhibits164: SQI Diagnostics Inc. - Product / Service
Exhibits165: SQI Diagnostics Inc. - Key offerings
Exhibits166: Sysmex Corp. - Overview
Exhibits167: Sysmex Corp. - Business segments
Exhibits168: Sysmex Corp. - Key offerings
Exhibits169: Sysmex Corp. - Segment focus
Exhibits170: Tecan Trading AG - Overview
Exhibits171: Tecan Trading AG - Business segments
Exhibits172: Tecan Trading AG - Key offerings
Exhibits173: Tecan Trading AG - Segment focus
Exhibits174: Thermo Fisher Scientific Inc. - Overview
Exhibits175: Thermo Fisher Scientific Inc. - Business segments
Exhibits176: Thermo Fisher Scientific Inc. - Key news
Exhibits177: Thermo Fisher Scientific Inc. - Key offerings
Exhibits178: Thermo Fisher Scientific Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations

この商品のレポートナンバー

0000035501

TOP